Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Dare Bioscience (DARE) over the last 10 years, with Q3 2025 value amounting to $109382.0.

  • Dare Bioscience's Non Operating Income rose 61712.37% to $109382.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5309.0, marking a year-over-year increase of 10070.84%. This contributed to the annual value of -$981490.0 for FY2024, which is 22607.63% down from last year.
  • Latest data reveals that Dare Bioscience reported Non Operating Income of $109382.0 as of Q3 2025, which was up 61712.37% from -$188683.0 recorded in Q2 2025.
  • Dare Bioscience's Non Operating Income's 5-year high stood at $340148.0 during Q1 2023, with a 5-year trough of -$732883.0 in Q1 2024.
  • In the last 5 years, Dare Bioscience's Non Operating Income had a median value of $29676.0 in 2022 and averaged $21117.4.
  • As far as peak fluctuations go, Dare Bioscience's Non Operating Income surged by 3435371.7% in 2022, and later tumbled by 31546.0% in 2024.
  • Dare Bioscience's Non Operating Income (Quarter) stood at $834.0 in 2021, then surged by 34353.72% to $287344.0 in 2022, then crashed by 60.36% to $113898.0 in 2023, then crashed by 203.78% to -$118201.0 in 2024, then soared by 192.54% to $109382.0 in 2025.
  • Its Non Operating Income stands at $109382.0 for Q3 2025, versus -$188683.0 for Q2 2025 and $202811.0 for Q1 2025.